Average Co-Inventor Count = 4.77
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (25 from 2,405 patents)
2. Mission Therapeutics Limited (14 from 31 patents)
3. Genentech, Inc. (8 from 3,221 patents)
4. Astex Therapeutics Limited (4 from 123 patents)
5. Other (1 from 832,680 patents)
6. Merck Frosst Canada & Co. (1 from 76 patents)
7. F. Hoffmann-la Roche Ag (168 patents)
52 patents:
1. 12378249 - Isoquinoline compounds and uses thereof
2. 12297210 - Naphthyridine compounds and uses thereof
3. 12208088 - Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
4. 11993595 - Compounds
5. 11958833 - Compounds
6. 11944606 - Azaindoles as inhibitors of HPK1
7. 11566003 - Isoquinolines as inhibitors of HPK1
8. 11472798 - Compounds
9. 11414402 - Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors
10. 11370784 - Cyano-substituted heterocycles with activity as inhibitors of USP30
11. 11130748 - Compounds
12. 11091488 - 1-cyano-pyrrolidine derivatives as inhibitors of USP30
13. 11084821 - Cyanopyrrolidine derivatives with activity as inhibitors of USP30
14. 11034692 - Naphthyridines as inhibitors of HPK1
15. 11014912 - Cyanopyrrolidine derivatives with activity as inhibitors of USP30